Blood Predictive Biomarkers for Nivolumab in Advanced Melanoma

• Главные авторы: Edouard Chasseuil (Автор), Mélanie Saint-Jean (Автор), Hannah Chasseuil (Автор), Lucie Peuvrel (Автор), Gaëlle Quéreux (Автор), Jean-Michel Nguyen (Автор), Aurélie Gaultier (Автор), Emilie Varey (Автор), Amir Khammari (Автор), Brigitte Dréno (Автор)
• Формат: ‌
• Опубликовано: Medical Journals Sweden, 2018-01-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Nivolumab response rate is 40% in metastatic melanoma. Few studies have evaluated pre-treatment biomarkers predictive of response. The aim of this study was to identify potential peripheral blood biomarkers associated with survival in patients with advanced melanoma treated with nivolumab. All advan...